Comment
Gemcitabine and cisplatin: second-line chemotherapy for malignant mesothelioma?
- PMID: 10561332
Item in Clipboard
Comment
Gemcitabine and cisplatin: second-line chemotherapy for malignant mesothelioma?
J Clin Oncol.
1999 Aug.
No abstract available
Comment on
-
Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study.J Clin Oncol. 1999 Jan;17(1):25-30. doi: 10.1200/JCO.1999.17.1.25. J Clin Oncol. 1999. PMID: 10458214 Clinical Trial.
Similar articles
-
[A case of malignant peritoneal mesothelioma treated effectively with cisplatin and gemcitabine].Gan To Kagaku Ryoho. 2010 Oct;37(10):1971-4. Gan To Kagaku Ryoho. 2010. PMID: 20948266 Japanese.
-
Cisplatin and gemcitabine in malignant mesothelioma.Ann Oncol. 2005 Oct;16(10):1711. doi: 10.1093/annonc/mdi303. Epub 2005 Jul 6. Ann Oncol. 2005. PMID: 16000339 No abstract available.
-
The role of gemcitabine in the treatment of malignant mesothelioma.Semin Oncol. 2002 Feb;29(1):70-6. doi: 10.1053/sonc.2002.30232. Semin Oncol. 2002. PMID: 11836671 Review.
-
Sequential chemotherapy with cisplatin/gemcitabine (CG) followed by mitoxantrone/methotrexate/mitomycin (MMM) in patients with malignant pleural mesothelioma. A multicenter Italian Phase II Study (SITMP1).Lung Cancer. 2006 May;52(2):199-206. doi: 10.1016/j.lungcan.2006.01.002. Epub 2006 Mar 20. Lung Cancer. 2006. PMID: 16542747 Clinical Trial.
-
Chemotherapy options and new advances in malignant pleural mesothelioma.Ann Oncol. 2005 Mar;16(3):345-51. doi: 10.1093/annonc/mdi094. Epub 2005 Jan 27. Ann Oncol. 2005. PMID: 15677623 Review.
Cited by
-
Chemotherapy treatment in malignant pleural mesothelioma: a difficult history.J Thorac Dis. 2018 Jan;10(Suppl 2):S304-S310. doi: 10.21037/jtd.2017.10.19. J Thorac Dis. 2018. PMID: 29507800 Free PMC article. Review.
-
Peritoneal mesothelioma.Curr Treat Options Oncol. 2000 Oct;1(4):303-12. doi: 10.1007/s11864-000-0046-5. Curr Treat Options Oncol. 2000. PMID: 12057156 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical